Trending News
News
News
Antibody–Drug Conjugate Reduces Risk of Death by 30% in Patients With Common Bladder Cancer
The antibody–drug conjugate (ADC) enfortumab vedotin (PADCEV®) has been shown to increase the survival of patients with urothelial carcinoma in a recent study. Results from the randomized open-label Phase 3 trial were published in the New England Journal of Medicine.
News
Using Machine Learning To Create Better Gene Therapies
Machine learning study initiated at the Wyss Institute in collaboration with Google Research enables unprecedented AAV capsid diversification with potential for improving gene therapies.
News
New Insights Could Facilitate the Development of Improved Chemical Cryoprotection Technologies
Scientists report major discoveries on how a class of molecules called polyampholytes can safely freeze biological materials.
News
Greater Inclusion of Pregnant People in COVID-19 Vaccine Research Is Called For
Longstanding obstacles to include pregnant and lactating people in clinical research have led to this population now deciding whether or not to receive a SARS-CoV-2 vaccine without the benefit of scientific evidence, scientists say.
News
Researchers Uncover How Anticancer Drug Rituximab Works
The first approved therapeutic antibody against B tumor cells was rituximab, an anti-cancer drug targeting the membrane protein CD20. Now, a team of immunologists has solved the mystery about how it works.
News
Engineering Biomaterials for Better Vaccines
Researchers describe two possibilities being explored by scientists in the field to make vaccines more effective and build surfaces that could fight and kill viruses on their own.
News
WHO Says Oxford’s Vaccine Is Safe and Likely to Be Efficacious in Older Adults
The World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) yesterday produced guidelines for the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine developed by the University of Oxford with its partner AstraZeneca.
News
Fighting Bacteria With Viruses in Hard-To-Reach Locations
A novel strategy using phage - viruses that infect bacteria - has the potential to become a game changer in the fight against antibiotic-resistant bacteria that live in hard-to-reach places.
News
FDA Authorizes Monoclonal Antibody Treatment of COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19.
News
Food Supplement Pigment Sourced From Microalgae
Through targeted cultivation, researchers obtained microalgae biomass with a high content of carotenoid pigments - essential to human health but often lacking in diets - which is suitable for the food industry.
Advertisement